Featured Research

from universities, journals, and other organizations

Chikungunya: The key role of 'innate immunity'

Date:
March 23, 2011
Source:
Institut de Recherche pour le Développement (IRD)
Summary:
Chikungunya is transmitted by mosquitoes of the genus Aedes. The disease is spreading in the world and periodically sparks new outbreaks. Blood analyses conducted during the 2007 Gabonese epidemic recently showed the key role of innate immunity, the organism's first line of defense, in the clinical course of the infection. Control of the disease thus closely depends on the underlying configuration of each patient's immune system.

Chikungunya is transmitted by mosquitoes of the genus Aedes. The disease is spreading in the world and periodically sparks new outbreaks. Africa, Asia, the Indian Ocean and even Southern Europe are now affected. The viral infection can be expressed in many different ways. Patients can suffer forms ranging from a simple fever to severe pain in the joints. This high variability in symptoms arises from the variability of humans' individual immune defence systems.

Blood analyses conducted during the 2007 Gabonese epidemic, studied by IRD researchers and their partners, recently showed the key role of innate immunity, the organism's first line of defence, in the clinical course of the infection. Control of the disease thus closely depends on the underlying configuration of each patient's immune system. The serious cases would therefore be due to a defect in the innate response, as happens in pregnant women, the aged, and other vulnerable groups. These investigations have brought new insights into this disease, insufficiently studied and neglected by public authorities.

Chikungunya virus, first isolated in Tanzania in 1953, caused a great number of epidemics in Africa and South-East Asia in the course of the 20th Century.

A global threat

This infectious disease, like yellow fever and dengue, is caused by an arbovirus, transmitted by blood-sucking arthropods, ticks and Phlebotominae or sand flies. Its main vectors are mosquitoes of the genus Aedes. Particularly concerned is Aedes albopictus, nicknamed the "tiger mosquito," whose eggs enable it rapidly to conquer new territories. Increasing human travel, which spreads the larvae, and the rising resistance of mosquitoes to insecticides have contributed to the rapid expansion of epidemics over the past few years, to new regions of the world: islands in the Indian Ocean, Central Africa and even, very recently, Southern Europe are now affected. The outbreak in Réunion Island in 2005-2006 hit over 260 000 people. The recent epidemic in southern Italy, in 2007, and also the first reported case of fever in the South of France illustrate the potential for world-wide diffusion, making this disease, rarely fatal but severely incapacitating, a major threat to public health.

Strong innate immunity

Ranging from a simple bout of fever to severe pain in the joints, chikungunya can take on many different forms. This very broad variability of symptoms is due to variations in the individual immune response of each patient. IRD researchers and their partners1 recently showed the key function of "innate immunity," the organism's first line of defence, in the clinical course of the disease.

Challenged by the presence of foreign DNA in the organism following a viral, bacterial or parasitic infection, or the presence of tumoral cells, the organism activates its immune system. This immune, or inflammatory response, occurs in two major stages: non-specific defence, also called "innate immunity," which does not take account of the nature of the micro-organism it is fighting, and the specific response, which targets the pathogenic agent in the infected cells.

In chikungunya patients, the first stage response is highly effective. Detailed analysis of nearly 70 blood plasma profiles taken during the 2007 epidemic in the Gabonese capital Libreville, revealed the presence, during the first four days of symptoms, of a high quantity of interferons, cytokines and chemokines,* immune-system substances akin to hormones- Interferons play a prime role in the immediate inflammation defence system. As the name indicates they interfere with replication of the virus in host cells and thus inhibit the virus early in the process. The function of cytokines and chemokines is to activate the second stage: the specific response. These proteins attract immune cells -leucocytes- to each virus replication site and direct the deployment of the organism's antiviral defences.

Control of the disease therefore depends closely on the underlying immune status of each patient. Severe cases could therefore be the result of a defect in the innate response mechanism, as can occur in pregnant women, elderly people or Aids patients.

A highly disabling disease

Serious forms can consequently appear, inducing highly disabling stiffening of the joints, the reason for the name of the disease: chikungunya meaning "bent man disease" in the Makonde language of Southern Africa. These symptoms generally last three to seven days, the time for the immune cells to work, but can also become chronic and persist for months, even years. Neurological and hepatic complications can also occur in the most severe forms. There is currently no specific treatment, so therapeutic care aims solely to alleviate these symptoms, using analgesic and anti-inflammatory drugs.

Medical professionals are at the dawn of their research on the disease, long neglected by government authorities. The research team is similarly exploring the role, in pathogen inhibition, of cells called Natural Killer, capable of killing directly the infected cells. In parallel, investigations are also under way on modulation of the immune response in cases of co-infection with dengue virus, recently discovered in Gabon, a new threat involving a simultaneous attack by the two severely debilitating diseases.

* Interferons, cytokines and chemokines are proteins produced by the cells of the immune system.


Story Source:

The above story is based on materials provided by Institut de Recherche pour le Développement (IRD). Note: Materials may be edited for content and length.


Journal Reference:

  1. N. Wauquier, P. Becquart, D. Nkoghe, C. Padilla, A. Ndjoyi-Mbiguino, E. M. Leroy. The Acute Phase of Chikungunya Virus Infection in Humans Is Associated with Strong Innate Immunity and T CD8 Cell Activation. Journal of Infectious Diseases, 2010; DOI: 10.1093/infdis/jiq006

Cite This Page:

Institut de Recherche pour le Développement (IRD). "Chikungunya: The key role of 'innate immunity'." ScienceDaily. ScienceDaily, 23 March 2011. <www.sciencedaily.com/releases/2011/03/110322115224.htm>.
Institut de Recherche pour le Développement (IRD). (2011, March 23). Chikungunya: The key role of 'innate immunity'. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/03/110322115224.htm
Institut de Recherche pour le Développement (IRD). "Chikungunya: The key role of 'innate immunity'." ScienceDaily. www.sciencedaily.com/releases/2011/03/110322115224.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins